These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1665377)

  • 1. Mechanisms of the analgesic actions of opiates and opioids.
    Dickenson AH
    Br Med Bull; 1991 Jul; 47(3):690-702. PubMed ID: 1665377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression.
    Shook JE; Watkins WD; Camporesi EM
    Am Rev Respir Dis; 1990 Oct; 142(4):895-909. PubMed ID: 2171388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociception induced by intrathecal coadministration of selective adenosine receptor and selective opioid receptor agonists in mice.
    De Lander GE; Keil GJ
    J Pharmacol Exp Ther; 1994 Feb; 268(2):943-51. PubMed ID: 8114009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of peristalsis in the guinea-pig isolated small intestine by exogenous and endogenous opioids.
    Waterman SA; Costa M; Tonini M
    Br J Pharmacol; 1992 Aug; 106(4):1004-10. PubMed ID: 1356564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
    Fang FG; Fields HL; Lee NM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid receptor affinities of kappa agonists, agonist/antagonists and antagonists in vitro and in vivo.
    Wood PL
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):657-62. PubMed ID: 6320302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
    Parsons CG; West DC; Headley PM
    Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evidence for different narcotic receptors and relevance for the clinician.
    Martin WR
    Ann Emerg Med; 1986 Sep; 15(9):1026-9. PubMed ID: 3017158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between highly selective mu and delta opioids in vivo at the rat spinal cord.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    NIDA Res Monogr; 1986; 75():97-100. PubMed ID: 2829017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioids and pain.
    Kanjhan R
    Clin Exp Pharmacol Physiol; 1995; 22(6-7):397-403. PubMed ID: 8582088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.
    Iyengar S; Kim HS; Wood PL
    J Pharmacol Exp Ther; 1986 Aug; 238(2):429-36. PubMed ID: 3016237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
    Lester PA; Traynor JR
    Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New developments and findings in the field of opiates, opioids, opiate receptors and complete and partial opiate antagonists].
    Schneider M; Bunge HJ; Heinrich F
    Anaesthesiol Reanim; 1990; 15(3):138-44. PubMed ID: 2168183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiates and enkephalins: a common binding site mediates their analgesic actions in rats.
    Zhang AZ; Pasternak GW
    Life Sci; 1981 Aug; 29(8):843-51. PubMed ID: 6272049
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of delta opioid peptides as nonaddicting analgesics.
    Rapaka RS; Porreca F
    Pharm Res; 1991 Jan; 8(1):1-8. PubMed ID: 1849640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
    Schmauss C; Yaksh TL
    J Pharmacol Exp Ther; 1984 Jan; 228(1):1-12. PubMed ID: 6319664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasticity: implications for opioid and other pharmacological interventions in specific pain states.
    Dickenson AH
    Behav Brain Sci; 1997 Sep; 20(3):392-403; discussion 435-513. PubMed ID: 10097002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral analgesic actions of opioids.
    Stein C
    J Pain Symptom Manage; 1991 Apr; 6(3):119-24. PubMed ID: 1849945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple opiate receptors: déjà vu all over again.
    Pasternak GW
    Neuropharmacology; 2004; 47 Suppl 1():312-23. PubMed ID: 15464147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu opioid receptors participate in the excitatory effect of opiates in the hippocampal slice.
    Bostock E; Dingledine R; Xu G; Chang KJ
    J Pharmacol Exp Ther; 1984 Dec; 231(3):512-7. PubMed ID: 6094789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.